Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1394 entries
Sorted by: Best Match Show Resources per page
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.

Frontiers in oncology

Al-Anazi KA, Al-Jasser AM.
PMID: 25202682
Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014.

Stenotrophomonas maltophilia (S. maltophilia) is a globally emerging Gram-negative bacillus that is widely spread in environment and hospital equipment. Recently, the incidence of infections caused by this organism has increased, particularly in patients with hematological malignancy and in recipients...

Cite
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014;4:232doi: 10.3389/fonc.2014.00232.
Al-Anazi, K. A., & Al-Jasser, A. M. (2014). Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in oncology, 4232. https://doi.org/10.3389/fonc.2014.00232
Al-Anazi, Khalid Ahmed, and Al-Jasser, Asma M. "Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation." Frontiers in oncology vol. 4 (2014): 232. doi: https://doi.org/10.3389/fonc.2014.00232
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014. PMID: 25202682; PMCID: PMC4142553.
Copy Download .nbib Format: NLM
Renal Abscess Caused by Salmonella Typhi.

Journal of laboratory physicians

Kaur A, Sarma S, Kumar N, Sengupta S.
PMID: 26417164
J Lab Physicians. 2015 Jul-Dec;7(2):121-3. doi: 10.4103/0974-2727.163132.

Salmonella typhi is a true pathogen, which is capable of causing both intestinal and extraintestinal infections. Unusual presentations of Salmonella should always be kept in mind as this organism can cause disease in almost any organ of the body....

Cite
Kaur A, Sarma S, Kumar N, et al. Renal Abscess Caused by Salmonella Typhi. J Lab Physicians. 2015;7(2):121-3doi: 10.4103/0974-2727.163132.
Kaur, A., Sarma, S., Kumar, N., & Sengupta, S. (2015). Renal Abscess Caused by Salmonella Typhi. Journal of laboratory physicians, 7(2), 121-3. https://doi.org/10.4103/0974-2727.163132
Kaur, Amarjeet, et al. "Renal Abscess Caused by Salmonella Typhi." Journal of laboratory physicians vol. 7,2 (2015): 121-3. doi: https://doi.org/10.4103/0974-2727.163132
Kaur A, Sarma S, Kumar N, Sengupta S. Renal Abscess Caused by Salmonella Typhi. J Lab Physicians. 2015 Jul-Dec;7(2):121-3. doi: 10.4103/0974-2727.163132. PMID: 26417164; PMCID: PMC4559625.
Copy Download .nbib Format: NLM
High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran.

Journal of natural science, biology, and medicine

Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J.
PMID: 27003964
J Nat Sci Biol Med. 2016 Jan-Jun;7(1):22-6. doi: 10.4103/0976-9668.175020.

BACKGROUND AND OBJECTIVES: Urinary tract infection (UTI) is one of the most frequent infectious diseases and can occur in all age groups. Escherichia coli is the main cause of this infection. Multiple resistances to antimicrobial agents are increasing quickly...

Cite
Dehbanipour R, Rastaghi S, Sedighi M, et al. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016;7(1):22-6doi: 10.4103/0976-9668.175020.
Dehbanipour, R., Rastaghi, S., Sedighi, M., Maleki, N., & Faghri, J. (2016). High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. Journal of natural science, biology, and medicine, 7(1), 22-6. https://doi.org/10.4103/0976-9668.175020
Dehbanipour, Razieh, et al. "High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran." Journal of natural science, biology, and medicine vol. 7,1 (2016): 22-6. doi: https://doi.org/10.4103/0976-9668.175020
Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016 Jan-Jun;7(1):22-6. doi: 10.4103/0976-9668.175020. PMID: 27003964; PMCID: PMC4780161.
Copy Download .nbib Format: NLM
Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India.

Veterinary world

Balakrishnan S, Antony PX, Mukhopadhyay HK, Pillai RM, Thanislass J, Padmanaban V, Srinivas MV.
PMID: 27536030
Vet World. 2016 Jul;9(7):705-9. doi: 10.14202/vetworld.2016.705-709. Epub 2016 Jul 11.

AIM: The present study was undertaken to characterize the mutation in gyrA (DNA gyrase) and parC (topoisomerase IV) genes responsible for fluoroquinolone resistance in Escherichia coli isolates associated with the bovine mastitis.MATERIALS AND METHODS: A total of 92 milk...

Cite
Balakrishnan S, Antony PX, Mukhopadhyay HK, et al. Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India. Vet World. 2016;9(7):705-9doi: 10.14202/vetworld.2016.705-709.
Balakrishnan, S., Antony, P. X., Mukhopadhyay, H. K., Pillai, R. M., Thanislass, J., Padmanaban, V., & Srinivas, M. V. (2016). Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India. Veterinary world, 9(7), 705-9. https://doi.org/10.14202/vetworld.2016.705-709
Balakrishnan, Sangeetha, et al. "Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India." Veterinary world vol. 9,7 (2016): 705-9. doi: https://doi.org/10.14202/vetworld.2016.705-709
Balakrishnan S, Antony PX, Mukhopadhyay HK, Pillai RM, Thanislass J, Padmanaban V, Srinivas MV. Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India. Vet World. 2016 Jul;9(7):705-9. doi: 10.14202/vetworld.2016.705-709. Epub 2016 Jul 11. PMID: 27536030; PMCID: PMC4983120.
Copy Download .nbib Format: NLM
Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea.

Tuberculosis and respiratory diseases

Kang BH, Jo KW, Shim TS.
PMID: 28416954
Tuberc Respir Dis (Seoul). 2017 Apr;80(2):143-152. doi: 10.4046/trd.2017.80.2.143. Epub 2017 Mar 31.

BACKGROUND: Fluoroquinolones are considered important substitutes for the treatment of tuberculosis. This study investigates the current status of fluoroquinolone for the treatment of tuberculosis.METHODS: In 2009, a retrospective analysis was performed at one tertiary referral center for 953 patients...

Cite
Kang BH, Jo KW, Shim TS. Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberc Respir Dis (Seoul). 2017;80(2):143-152doi: 10.4046/trd.2017.80.2.143.
Kang, B. H., Jo, K. W., & Shim, T. S. (2017). Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberculosis and respiratory diseases, 80(2), 143-152. https://doi.org/10.4046/trd.2017.80.2.143
Kang, Bo Hyoung, et al. "Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea." Tuberculosis and respiratory diseases vol. 80,2 (2017): 143-152. doi: https://doi.org/10.4046/trd.2017.80.2.143
Kang BH, Jo KW, Shim TS. Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberc Respir Dis (Seoul). 2017 Apr;80(2):143-152. doi: 10.4046/trd.2017.80.2.143. Epub 2017 Mar 31. PMID: 28416954; PMCID: PMC5392485.
Copy Download .nbib Format: NLM
Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.

Journal of research in pharmacy practice

Singh AK, Jain S, Kumar D, Singh RP, Bhatt H.
PMID: 26312255
J Res Pharm Pract. 2015 Jul-Sep;4(3):153-9. doi: 10.4103/2279-042X.162363.

OBJECTIVE: There is an increased prevalence of extended-spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-KP) worldwide including India, which is a major concern for the clinicians, especially in intensive care units and pediatric patients. This study aims to determine the prevalence...

Cite
Singh AK, Jain S, Kumar D, et al. Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital. J Res Pharm Pract. 2015;4(3):153-9doi: 10.4103/2279-042X.162363.
Singh, A. K., Jain, S., Kumar, D., Singh, R. P., & Bhatt, H. (2015). Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital. Journal of research in pharmacy practice, 4(3), 153-9. https://doi.org/10.4103/2279-042X.162363
Singh, Amit Kumar, et al. "Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital." Journal of research in pharmacy practice vol. 4,3 (2015): 153-9. doi: https://doi.org/10.4103/2279-042X.162363
Singh AK, Jain S, Kumar D, Singh RP, Bhatt H. Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital. J Res Pharm Pract. 2015 Jul-Sep;4(3):153-9. doi: 10.4103/2279-042X.162363. PMID: 26312255; PMCID: PMC4548435.
Copy Download .nbib Format: NLM
Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey.

Antimicrobial resistance and infection control

Parascandalo FA, Zarb P, Tartari E, Lacej D, Bitincka S, Manastirliu O, Nika D, Borg MA.
PMID: 27499852
Antimicrob Resist Infect Control. 2016 Aug 05;5:29. doi: 10.1186/s13756-016-0128-1. eCollection 2016.

BACKGROUND: Antimicrobial resistance has been recognised as a serious global Public Health problem. Prevalence of Multiple-Drug-Resistant (MDR) organism carriage in Albania is largely unknown since no national surveillance system is in place and few publications are accessible in the...

Cite
Parascandalo FA, Zarb P, Tartari E, et al. Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrob Resist Infect Control. 2016;5:29doi: 10.1186/s13756-016-0128-1.
Parascandalo, F. A., Zarb, P., Tartari, E., Lacej, D., Bitincka, S., Manastirliu, O., Nika, D., & Borg, M. A. (2016). Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrobial resistance and infection control, 529. https://doi.org/10.1186/s13756-016-0128-1
Parascandalo, Falzon A, et al. "Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey." Antimicrobial resistance and infection control vol. 5 (2016): 29. doi: https://doi.org/10.1186/s13756-016-0128-1
Parascandalo FA, Zarb P, Tartari E, Lacej D, Bitincka S, Manastirliu O, Nika D, Borg MA. Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania-a point prevalence survey. Antimicrob Resist Infect Control. 2016 Aug 05;5:29. doi: 10.1186/s13756-016-0128-1. eCollection 2016. PMID: 27499852; PMCID: PMC4975909.
Copy Download .nbib Format: NLM
The emergence of multidrug-resistant .

Lung India : official organ of Indian Chest Society

AbdulWahab A, Zahraldin K, Sid Ahmed MA, Jarir SA, Muneer M, Mohamed SF, Hamid JM, Hassan AAI, Ibrahim EB.
PMID: 29098998
Lung India. 2017 Nov-Dec;34(6):527-531. doi: 10.4103/lungindia.lungindia_39_17.

INTRODUCTION: Multidrug-resistant Pseudomonas aeruginosa (MDR-PA) is an important and growing issue in the care of patients with cystic fibrosis (CF), and a major cause of morbidity and mortality.OBJECTIVE: The objective of the study was to describe the frequency of...

Cite
AbdulWahab A, Zahraldin K, Sid Ahmed MA, et al. The emergence of multidrug-resistant . Lung India. 2017;34(6):527-531doi: 10.4103/lungindia.lungindia_39_17.
AbdulWahab, A., Zahraldin, K., Sid Ahmed, M. A., Jarir, S. A., Muneer, M., Mohamed, S. F., Hamid, J. M., Hassan, A. A. I., & Ibrahim, E. B. (2017). The emergence of multidrug-resistant . Lung India : official organ of Indian Chest Society, 34(6), 527-531. https://doi.org/10.4103/lungindia.lungindia_39_17
AbdulWahab, Atqah, et al. "The emergence of multidrug-resistant ." Lung India : official organ of Indian Chest Society vol. 34,6 (2017): 527-531. doi: https://doi.org/10.4103/lungindia.lungindia_39_17
AbdulWahab A, Zahraldin K, Sid Ahmed MA, Jarir SA, Muneer M, Mohamed SF, Hamid JM, Hassan AAI, Ibrahim EB. The emergence of multidrug-resistant . Lung India. 2017 Nov-Dec;34(6):527-531. doi: 10.4103/lungindia.lungindia_39_17. PMID: 29098998; PMCID: PMC5684810.
Copy Download .nbib Format: NLM
Nosocomial bacteremia due to Kluyvera cryocrescens: Case report and literature review.

IDCases

Yoshino Y, Nakazawa S, Otani S, Sekizuka E, Ota Y.
PMID: 27051581
IDCases. 2016 Mar 04;4:24-6. doi: 10.1016/j.idcr.2016.02.007. eCollection 2016.

Kluyvera cryocrescens infection has been considered rare; clinical features of K. cryocrescens bacteremia remain unclear because few reports have been published. We report a case of K. cryocrescens bacteremia in an adult male patient and review the literature. Our...

Cite
Yoshino Y, Nakazawa S, Otani S, et al. Nosocomial bacteremia due to Kluyvera cryocrescens: Case report and literature review. IDCases. 2016;4:24-6doi: 10.1016/j.idcr.2016.02.007.
Yoshino, Y., Nakazawa, S., Otani, S., Sekizuka, E., & Ota, Y. (2016). Nosocomial bacteremia due to Kluyvera cryocrescens: Case report and literature review. IDCases, 424-6. https://doi.org/10.1016/j.idcr.2016.02.007
Yoshino, Yusuke, et al. "Nosocomial bacteremia due to Kluyvera cryocrescens: Case report and literature review." IDCases vol. 4 (2016): 24-6. doi: https://doi.org/10.1016/j.idcr.2016.02.007
Yoshino Y, Nakazawa S, Otani S, Sekizuka E, Ota Y. Nosocomial bacteremia due to Kluyvera cryocrescens: Case report and literature review. IDCases. 2016 Mar 04;4:24-6. doi: 10.1016/j.idcr.2016.02.007. eCollection 2016. PMID: 27051581; PMCID: PMC4802674.
Copy Download .nbib Format: NLM
The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.

International journal of mycobacteriology

Daneau G, Gumusboga M, De Rijk P, Trebucq A, Rigouts L, Van Deun A, de Jong BC.
PMID: 28043604
Int J Mycobacteriol. 2016 Dec;5:S46-S47. doi: 10.1016/j.ijmyco.2016.10.015. Epub 2016 Oct 27.

OBJECTIVE/BACKGROUND: Pyrazinamide (PZA) is an antibacterial used in the first-line regimen against tuberculosis (TB) for its action against dormant bacilli. PZA is also included in the new short regimen to treat multidrug-resistant TB (MDR-TB). However, the prevalence and significance...

Cite
Daneau G, Gumusboga M, De Rijk P, et al. The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide. Int J Mycobacteriol. 2016;5:S46-S47doi: 10.1016/j.ijmyco.2016.10.015.
Daneau, G., Gumusboga, M., De Rijk, P., Trebucq, A., Rigouts, L., Van Deun, A., & de Jong, B. C. (2016). The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide. International journal of mycobacteriology, 5S46-S47. https://doi.org/10.1016/j.ijmyco.2016.10.015
Daneau, Géraldine, et al. "The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide." International journal of mycobacteriology vol. 5 (2016): S46-S47. doi: https://doi.org/10.1016/j.ijmyco.2016.10.015
Daneau G, Gumusboga M, De Rijk P, Trebucq A, Rigouts L, Van Deun A, de Jong BC. The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide. Int J Mycobacteriol. 2016 Dec;5:S46-S47. doi: 10.1016/j.ijmyco.2016.10.015. Epub 2016 Oct 27. PMID: 28043604.
Copy Download .nbib Format: NLM
Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to .

Frontiers in microbiology

Alvarado M, Martín-Galiano AJ, Ferrándiz MJ, Zaballos Á, de la Campa AG.
PMID: 29123510
Front Microbiol. 2017 Oct 26;8:2074. doi: 10.3389/fmicb.2017.02074. eCollection 2017.

We characterized the mechanism of fluoroquinolone-resistance in two isolates of

Cite
Alvarado M, Martín-Galiano AJ, Ferrándiz MJ, et al. Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to . Front Microbiol. 2017;8:2074doi: 10.3389/fmicb.2017.02074.
Alvarado, M., Martín-Galiano, A. J., Ferrándiz, M. J., Zaballos, �. �., & de la Campa, A. G. (2017). Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to . Frontiers in microbiology, 82074. https://doi.org/10.3389/fmicb.2017.02074
Alvarado, María, et al. "Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to ." Frontiers in microbiology vol. 8 (2017): 2074. doi: https://doi.org/10.3389/fmicb.2017.02074
Alvarado M, Martín-Galiano AJ, Ferrándiz MJ, Zaballos Á, de la Campa AG. Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to . Front Microbiol. 2017 Oct 26;8:2074. doi: 10.3389/fmicb.2017.02074. eCollection 2017. PMID: 29123510; PMCID: PMC5662624.
Copy Download .nbib Format: NLM
Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics.

Electrophoresis

Kaale E, Höllein L, Holzgrabe U.
PMID: 25963935
Electrophoresis. 2015 Nov;36(21):2736-2744. doi: 10.1002/elps.201500025. Epub 2015 Jun 26.

In this paper, a reliable stability-indicating generic MEEKC method for the analysis of five commonly used fluoroquinolones (FQs) has been developed and optimized by a central composite circumscribed experimental design. The separation was carried out using a fused silica...

Cite
Kaale E, Höllein L, Holzgrabe U. Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics. Electrophoresis. 2015;36(21):2736-2744doi: 10.1002/elps.201500025.
Kaale, E., Höllein, L., & Holzgrabe, U. (2015). Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics. Electrophoresis, 36(21), 2736-2744. https://doi.org/10.1002/elps.201500025
Kaale, Eliangiringa, et al. "Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics." Electrophoresis vol. 36,21 (2015): 2736-2744. doi: https://doi.org/10.1002/elps.201500025
Kaale E, Höllein L, Holzgrabe U. Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics. Electrophoresis. 2015 Nov;36(21):2736-2744. doi: 10.1002/elps.201500025. Epub 2015 Jun 26. PMID: 25963935.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1394 entries